Compare ARK Genomic Revolution ETF (ARKG) vs Oatly Group AB - ADR (OTLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Oatly Group AB - ADR — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Oatly Group AB - ADR trades at $9.85 (market cap $307.57M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Oatly Group AB - ADR nearer its low. Which is the better fit depends on your goals.
| ARKG | OTLY | |
|---|---|---|
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $43.57 | $18.54 |
52-Week Low | $23.09 | $8.03 |
Market Cap | — | $307.57M |
Enterprise Value | — | $805.18M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
OTLY trades at $9.85, up 2.82% today, with a bullish technical signal from ADX indicators. Revenue growth is steady, reaching $862M in 2025, but profitability remains elusive with a net income margin of -17.06%. The company continues to burn cash, though the rate has improved from previous years. Recent news includes new product launches in Canada and an upcoming Q2 2026 earnings report on July 22, 2026.
The outlook is mixed: strong brand presence and revenue growth offer potential, but persistent losses, high debt, and negative cash flow pose significant risks. Analyst sentiment is divided, with 44% recommending buy and 50% hold. Investment hinges on OTLY's ability to achieve profitability and manage its cash runway effectively.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →
